search icon
vera-img

Vera Therapeutics Inc, Common Stock

VERA

NMQ

$19.93

+$1.06

(5.62%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.25B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.79M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.28
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$18.53 L
$51.61 H
$19.93

About Vera Therapeutics Inc, Common Stock

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with serious immunological diseases. The company's lead product candidate consists of atacicept, a fully humanized TACI-Fc fusion protein that binds B-cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL), which is self-administered at home as a subcutaneous injection being evaluated for the treatment of immunoglobulin A nephropathy (IgAN). It is also developing MAU868, a human monoclonal antibody for the treatment of BK viremia infections that has completed phase 2 clinical trial; and VT-109, a novel BAFF/APRIL dual-inhibitor B cell maturation antigen (BCMA) molecule to treat B cell mediated autoimmune diseases. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameVERASectorS&P500
1-Week Return1.53%0.71%0.79%
1-Month Return-16.96%-5.6%6.04%
3-Month Return-33.41%-11.72%-1.11%
6-Month Return-59.94%-10.81%-2.39%
1-Year Return-46.31%-7.12%11.69%
3-Year Return37.07%-0.57%42.29%
5-Year Return73.3%27.64%93.12%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue---1.86M-[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue251.00K176.00K(846.00K)(1.86M)-[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":70.12,"profit":true},{"date":"2022-12-31","value":-337.05,"profit":false},{"date":"2023-12-31","value":-741.83,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit(251.00K)(176.00K)846.00K1.86M-[{"date":"2020-12-31","value":-13.48,"profit":false},{"date":"2021-12-31","value":-9.45,"profit":false},{"date":"2022-12-31","value":45.44,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin---100.00%-[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses49.24M34.40M90.90M102.01M167.17M[{"date":"2020-12-31","value":29.46,"profit":true},{"date":"2021-12-31","value":20.58,"profit":true},{"date":"2022-12-31","value":54.38,"profit":true},{"date":"2023-12-31","value":61.02,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(52.24M)(34.40M)(90.90M)(102.01M)(167.17M)[{"date":"2020-12-31","value":-5224100000,"profit":false},{"date":"2021-12-31","value":-3440200000,"profit":false},{"date":"2022-12-31","value":-9090300000,"profit":false},{"date":"2023-12-31","value":-10201200000,"profit":false},{"date":"2024-12-31","value":-16717000000,"profit":false}]
Total Non-Operating Income/Expense(1.27M)1.79M2.61M9.61M28.11M[{"date":"2020-12-31","value":-4.5,"profit":false},{"date":"2021-12-31","value":6.36,"profit":true},{"date":"2022-12-31","value":9.27,"profit":true},{"date":"2023-12-31","value":34.18,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(53.41M)(32.61M)(89.06M)(95.99M)(152.15M)[{"date":"2020-12-31","value":-5341200000,"profit":false},{"date":"2021-12-31","value":-3260800000,"profit":false},{"date":"2022-12-31","value":-8905500000,"profit":false},{"date":"2023-12-31","value":-9598900000,"profit":false},{"date":"2024-12-31","value":-15214700000,"profit":false}]
Income Taxes1.00K1.00K1.00K1.00K1.00K[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes(53.41M)(32.61M)(89.06M)(95.99M)(152.15M)[{"date":"2020-12-31","value":-5341300000,"profit":false},{"date":"2021-12-31","value":-3260900000,"profit":false},{"date":"2022-12-31","value":-8905600000,"profit":false},{"date":"2023-12-31","value":-9599000000,"profit":false},{"date":"2024-12-31","value":-15214800000,"profit":false}]
Income From Continuous Operations(53.41M)(32.61M)89.06M(102.77M)(152.15M)[{"date":"2020-12-31","value":-59.98,"profit":false},{"date":"2021-12-31","value":-36.62,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-115.4,"profit":false},{"date":"2024-12-31","value":-170.85,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(53.41M)(32.61M)(89.06M)(95.99M)(152.15M)[{"date":"2020-12-31","value":-5341300000,"profit":false},{"date":"2021-12-31","value":-3260900000,"profit":false},{"date":"2022-12-31","value":-8905600000,"profit":false},{"date":"2023-12-31","value":-9599000000,"profit":false},{"date":"2024-12-31","value":-15214800000,"profit":false}]
EPS (Diluted)-(14.21)(3.35)(2.31)(2.75)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-1420.53,"profit":false},{"date":"2022-12-31","value":-335,"profit":false},{"date":"2023-12-31","value":-231,"profit":false},{"date":"2024-12-31","value":-275,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

VERA
Cash Ratio 26.94
Current Ratio 27.68

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

VERA
ROA (LTM) -23.46%
ROE (LTM) -39.49%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

VERA
Debt Ratio Lower is generally better. Negative is bad. 0.12
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.88

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

VERA
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 2.27
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Vera Therapeutics Inc share price today?

Vera Therapeutics Inc (VERA) share price today is $19.93

Can Indians buy Vera Therapeutics Inc shares?

Yes, Indians can buy shares of Vera Therapeutics Inc (VERA) on Vested. To buy Vera Therapeutics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in VERA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Vera Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Vera Therapeutics Inc (VERA) via the Vested app. You can start investing in Vera Therapeutics Inc (VERA) with a minimum investment of $1.

How to invest in Vera Therapeutics Inc shares from India?

You can invest in shares of Vera Therapeutics Inc (VERA) via Vested in three simple steps:

  • Click on Sign Up or Invest in VERA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Vera Therapeutics Inc shares
What is Vera Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Vera Therapeutics Inc (VERA) is $51.61. The 52-week low price of Vera Therapeutics Inc (VERA) is $18.53.

What is Vera Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Vera Therapeutics Inc (VERA) is 2.27

What is the Market Cap of Vera Therapeutics Inc?

The market capitalization of Vera Therapeutics Inc (VERA) is $1.25B

What is Vera Therapeutics Inc’s stock symbol?

The stock symbol (or ticker) of Vera Therapeutics Inc is VERA

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top